RxNorm 2642200 NDC Crossover
influenza virus vaccine 2023-2024 (quadrivalent - Darwin/Victoria/Michigan/Phuket) 0.5 ML
Related NDC Codes to RxNorm Concept 2642200
The following NDC codes crossover to the RxNorm Concept 2642200. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
|---|---|---|---|---|---|---|---|
| 49281-418 | Fluzone Quadrivalent Northern Hemisphere | Influenza A Virus A/michigan/45/2015 X-275 (h1n1) Hemagglutinin Antigen (formaldehyde Inactivated), Influenza A Virus A/singapore/infimh-16-0019/2016 Ivr-186 (h3n2) Hemagglutinin Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Hemagglutinin Antigen (formaldehyde Inactivated), Influenza B Virus B/maryland/15/2016 Bx-69a Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
| 49281-420 | Fluzone Quadrivalent Northern Hemisphere | Influenza A Virus A/guangdong-maonan/swl1536/2019 Cnic-1909 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/hong Kong/2671/2019 Ivr-208 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), Influenza B Virus B/washington/02/2019 Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
| 49281-421 | Fluzone Quadrivalent Northern Hemisphere | Influenza A Virus A/victoria/2570/2019 Ivr-215 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/tasmania/503/2020 Ivr-221 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), Influenza B Virus B/washington/02/2019 Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
| 49281-422 | Fluzone Quadrivalent Northern Hemisphere | Influenza A Virus A/victoria/2570/2019 Ivr-215 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/darwin/9/2021 San-010 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
| 49281-423 | Fluzone Quadrivalent Northern Hemisphere | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/darwin/9/2021 San-010 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
| 49281-519 | Fluzone Quadrivalent Northern Hemisphere | Influenza A Virus A/brisbane/02/2018 Ivr-190 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/kansas/14/2017 X-327 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), Influenza B Virus B/maryland/15/2016 Bx-69a Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
| 49281-629 | Fluzone Quadrivalent Northern Hemisphere | Influenza A Virus A/michigan/45/2015 X-275 (h1n1) Hemagglutinin Antigen (formaldehyde Inactivated), Influenza A Virus A/singapore/infimh-16-0019/2016 Ivr-186 (h3n2) Hemagglutinin Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Hemagglutinin Antigen (formaldehyde Inactivated), Influenza B Virus B/maryland/15/2016 Bx-69a Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
| 49281-631 | Fluzone Quadrivalent Northern Hemisphere | Influenza A Virus A/brisbane/02/2018 Ivr-190 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/kansas/14/2017 X-327 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), Influenza B Virus B/maryland/15/2016 Bx-69a Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
| 49281-633 | Fluzone Quadrivalent Northern Hemisphere | Influenza A Virus A/guangdong-maonan/swl1536/2019 Cnic-1909 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/hong Kong/2671/2019 Ivr-208 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), Influenza B Virus B/washington/02/2019 Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
| 49281-635 | Fluzone Quadrivalent Northern Hemisphere | Influenza A Virus A/victoria/2570/2019 Ivr-215 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/tasmania/503/2020 Ivr-221 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), Influenza B Virus B/washington/02/2019 Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
| 49281-637 | Fluzone Quadrivalent Northern Hemisphere | Influenza A Virus A/victoria/2570/2019 Ivr-215 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/darwin/9/2021 San-010 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
| 49281-639 | Fluzone Quadrivalent Northern Hemisphere | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/darwin/9/2021 San-010 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE |